Stocks and InvestingStocks and Investing
Thu, June 3, 2021
Wed, June 2, 2021
Tue, June 1, 2021
Fri, May 28, 2021
Thu, May 27, 2021

David Lebowitz Initiated (ARQT) at Buy and Held Target at $52 on, May 27th, 2021


Published on 2024-10-27 16:50:15 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Initiated "Arcutis Biotherapeutics, Inc." (ARQT) at Buy and Held Target at $52 on, May 27th, 2021.

David has made no other calls on ARQT in the last 4 months.



There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Gregg Gilbert of "Truist Securities" Maintained at Strong Buy with Increased Target to $48 on, Tuesday, February 2nd, 2021
  • Ken Cacciatore of "Cowen & Co." Maintained at Buy with Increased Target to $80 on, Monday, February 1st, 2021